The role of macrolides in the treatment of chronic rhinosinusits: an update on the evidence and safety

Rate this item
(4 votes)


Antibiotics are the most commonly prescribed drug class for patients with chronic rhinosinusistis (CRS) even through the causative role of bacteria remains unclear.

However, recent concern has been raised regarding the potential association of macrolide antibiotics and cardiotoxic side effects. This article reviews the evidence and safety of the role of macrolides in the management of patients with CRS.

Additional Info

  • Authors: S Toma, W Ahmed & C Hopkins
  • Keywords: Chronic rhinosinusitis, macrolides, antibiotics, cardiotoxicity, drug interactions.
Read 12568 times Last modified on Wednesday, 13 May 2020 12:49

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.


Member Login

          Forgot login? | Register

BBC News Feed

Get in touch

+44 207 637 3544

This email address is being protected from spambots. You need JavaScript enabled to view it.

The Otorhinolaryngologist,
73 Newman Street, London
W1T 3EJ, 


Rila Publications Ltd Ethics Policy